Comparison of the Efficacy of Mesotherapy and Extracorporeal Shock Wave Therapy in Patients With Lateral Epicondylitis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorHaydarpasa Numune Training and Research Hospital

About this trial

The goal of this clinical trial is to investigate the efficacy of mesotherapy in patients with lateral epicondylitis and to determine whether it is as effective as extracorporeal shock wave therapy (ESWT).

Is mesotherapy an effective method in patients with lateral epicondylitis?

Researchers will compare Mesotherapy to extracorporeal shock wave therapy (ESWT) in patient with Lateral epicondylitis.

Patients will be randomly assigned to either the Mesotherapy group or the ESWT group using a closed envelope method.

* Group 1 (Mesotherapy group): Patients will receive a total of 5 sessions of mesotherapy, with one session every 7 days. * Group 2 (ESWT group): Patients will receive a total of 5 sessions of Extracorporeal Shock Wave Therapy (ESWT), with one session every 7 days.

Patients will be assessed at three time points: before treatment, 30 minutes after the completion of the treatment, and 12 weeks after the completion of the treatment

Eligibility criteria

Qualifiers

Aged between 18 and 65 years

Pain and tenderness in the unilateral lateral epicondyle for ≥6 weeks

Clinically diagnosed with Lateral Epicondylitis

Patients without cognitive deficits who can follow verbal instructions

Disqualifiers

Receiving an interventional injection in the elbow region within the last 3 months

Receiving physical therapy in the last 3 months

Receiving regular nonsteroidal anti-inflammatory drug (NSAID) treatment in the last 2 weeks

History of fracture or surgery in the affected elbow region

Trial design

Treatments tested in this trial

  • Extracorporeal Shock Wave Therapy
  • Mesotherapy

Treatment groups

50 Participants
are divided into 2 treatment groups